What happened
Hyosung Chemical filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$613M (+41.22% year on year), operating profit of US$120M (from a loss a year earlier) and net income of US$110M (+52.35% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$613M |
|---|---|
| Revenue vs a year earlier | +41.22% |
| Operating profit | US$120M |
| Net income | US$110M |
| Period | Q2 2026 (consolidated) |
| Filed | 2026-07-31, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260731801123 → open original filing |
Source: DART. Information only, not investment advice.